Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 31,111 | 30,278 | 21,591 | 2 | -29,126 |
| Depreciation Amortization | 10,938 | 11,524 | 11,519 | 9,840 | 11,305 |
| Income taxes - deferred | 3,245 | -7,075 | N/A | N/A | N/A |
| Accounts receivable | -21,281 | 16,345 | -8,368 | -7,824 | -5,983 |
| Accounts payable and accrued liabilities | -453 | -1,380 | 449 | -4,734 | -902 |
| Other Working Capital | -10,078 | -3,535 | -17,854 | -44,496 | -1,309 |
| Other Operating Activity | 28,320 | -7,239 | 19,672 | 31,385 | 46,665 |
| Operating Cash Flow | $41,802 | $38,918 | $27,009 | $-15,827 | $20,650 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -71 | -56 | -140 | N/A | N/A |
| Purchase Of Investment | -108,141 | -76,230 | -23,813 | -4,836 | -38,073 |
| Sale Of Investment | 72,024 | 55,848 | 17,328 | 18,940 | 27,192 |
| Purchase Sale Intangibles | N/A | N/A | -12,500 | -7,000 | N/A |
| Other Investing Activity | 0 | 0 | -12,500 | -7,000 | 0 |
| Investing Cash Flow | $-36,188 | $-20,438 | $-19,125 | $7,104 | $-10,881 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 98,500 |
| Debt Repayment | -44,440 | -33,330 | N/A | N/A | -100,000 |
| Common Stock Issued | 130 | 150 | N/A | 12,500 | N/A |
| Other Financing Activity | -888 | -666 | 0 | -277 | -30,431 |
| Financing Cash Flow | $-45,198 | $-33,846 | $N/A | $12,223 | $-31,931 |
| Beginning Cash Position | 71,310 | 86,676 | 78,792 | 75,292 | 97,454 |
| End Cash Position | 31,726 | 71,310 | 86,676 | 78,792 | 75,292 |
| Net Cash Flow | $-39,584 | $-15,366 | $7,884 | $3,500 | $-22,162 |
| Free Cash Flow | |||||
| Operating Cash Flow | 41,802 | 38,918 | 27,009 | -15,827 | 20,650 |
| Capital Expenditure | -71 | -56 | -140 | N/A | N/A |
| Free Cash Flow | 41,731 | 38,862 | 26,869 | -15,827 | 20,650 |